Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.5.2.55NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.76ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.76ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.76ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.76NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.1.30ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.1.30ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.1.30ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.30NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BE.11ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BE.11ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BE.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BE.11NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.2.9ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.2.9ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
BA.5.2.9NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BF.31ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BF.31ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.31ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.31NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.4.6ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.4.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.4.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.4.6NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BF.24ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BF.24ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.24ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.24NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BF.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BF.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.6.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.6.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.6.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.6.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.1.10ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.1.10ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.1.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.10NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BF.41ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BF.41ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.41ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
BF.41NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BS.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BS.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BS.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BS.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.1.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used